Merit Medical launches Resilience TTS Esophageal Stent to address clinical gaps and expand its endoscopy portfolio with an advanced anti-migration design.

An NHS diabetes drug costing as little as 2p per table could cut the risk of one of the world's deadliest cancers that's on the rise in the UK, according to a new study.

New Resilience™ deployment system, anti-migration stent design, and unique stent sizes offer physicians control while enhancing treatment for patients with esophageal fistulas and malignant ...